SCHEMBL3946751

SCHEMBL3946751

COc1cccc(O)c1-c1cc(C)nc(N)n1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 9/20 0.71
HSP90AB1 P08238 6/20 0.57
IKBKB O14920 1/20 0.45
CHRNA7 P36544 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
TP53 P04637 2/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42
ALOX12 P18054 1/20 0.42
MAPK1 P28482 1/20 0.42
HSD17B10 Q99714 1/20 0.42
RAB9A P51151 2/20 0.40
DCPS Q96C86 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3952648 0.90 HSP90AA1 (0.81) HSP90AA1HSP90AB1CHRNA7ALDH1A1KDM4E
SCHEMBL3943592 0.84 HSP90AA1 (0.81) HSP90AA1HSP90AB1IKBKBCHRNA7MEN1
SCHEMBL14359627 0.83 HSP90AA1 (0.75) HSP90AA1HSP90AB1IKBKBMEN1KMT2A
SCHEMBL3951578 0.83 HSP90AA1 (1.00) HSP90AA1HSP90AB1CHRNA7ALDH1A1RAB9A
SCHEMBL3942054 0.76 HSP90AA1 (1.00) HSP90AA1HSP90AB1CHRNA7ALDH1A1KDM4E
SCHEMBL8441978 0.76 MEN1 (0.47) HSP90AA1HSP90AB1IKBKBMEN1KMT2A
SCHEMBL3952084 0.75 HSP90AA1 (0.71) HSP90AA1HSP90AB1CHRNA7ALDH1A1KDM4E
SCHEMBL7235549 0.75 TP53 (0.53) HSP90AA1HSP90AB1IKBKBMEN1KMT2A
SCHEMBL3945239 0.74 HSP90AA1 (0.61) HSP90AA1HSP90AB1KDM4EPIK3CDPIK3CA
SCHEMBL3951313 0.73 HSP90AA1 (1.00) HSP90AA1HSP90AB1CHRNA7ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors ASTEX THERAPEUTICS LTD. (GB) 2009-08-27 US disclosed
EP-2049497-A2 PYRIMIDINE DERIVATIVES AS HSP90 INHIBITORS Astex Therapeutics Limited (GB) 2009-04-22 EP disclosed
WO-2006123165-A2 PYRIMIDINE DERIVATIVES AS HSP90 INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215777-A1 Pyrimidine Derivatives As HSP90 Inhibitors HSP90AB1, HSP90AB2P, HSP90B1 HSP90AA1 4/4885HSP90AB1 1/4885IKBKB 618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.